Business Standard

EU not to renew AstraZeneca, J&J Covid-19 vaccine contracts on expiry

A spokesman for the EU Commission said it was keeping all options open to be prepared for the next stages of the pandemic, for 2022 and beyond

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

South Africa is facing delays to vaccine supplies because of “unreasonable terms” being demanded by manufacturers

Agencies
The European Union (EU) Commission has decided not to renew Covid-19 vaccine contracts next year with AstraZeneca and Johnson & Johnson (J&J), Italian daily La Stampa reported on Wednesday, citing a source from the Italian health ministry.
 
“The European Commission, in agreement with the leaders of many (EU) countries, has decided that the contracts with the companies that produce (viral vector) vaccines that are valid for the current year will not be renewed at their expiry,” the newspaper reported.
 
It added that Brussels would rather focus on Covid-19 vaccines using messenger RNA (mRNA) technology, such as Pfizer's and

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 15 2021 | 1:49 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com